Clinical Trial

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

Name: Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension — clinical trial record (NCT07297797)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the efficacy and safety of HRS-9563 in patients with mild to moderate hypertension, and to explore its appropriate dosage.

Protocol Amendment History 2 changes

critical Enrollment closed, study ongoing 2026-08-01

notable Primary completion pushed: 2026-07 -> 2026-12 2026-08-01

Trial Details

NCT Number	NCT07297797
Lead Sponsor	Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions	Mild to Moderate Hypertension
Enrollment	238 participants
Start Date	2026-01-14
Primary Completion	2026-12 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-31